Alpha Tau Medical Ltd
DRTS7.110USD
+0.250+3.64%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
606.23MMarket Cap
LossP/E TTM
More Details of Alpha Tau Medical Ltd Company
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.
Alpha Tau Medical Ltd Info
Ticker SymbolDRTS
Company nameAlpha Tau Medical Ltd
IPO dateMar 08, 2022
CEOSofer (Uzi)
Number of employees125
Security typeOrdinary Share
Fiscal year-endMar 08
AddressKiryat Hamada 5
CityJERUSALEM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code9777605
Phone97235774115
Websitehttps://www.alphatau.com/
Ticker SymbolDRTS
IPO dateMar 08, 2022
CEOSofer (Uzi)
Company Executives of Alpha Tau Medical Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Uzi Sofer
Mr. Uzi Sofer
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
11.52M
--
Mr. Michael Avruch
Mr. Michael Avruch
Independent Director
Independent Director
1.55M
+2708.00%
Prof. Yona Keisari
Prof. Yona Keisari
Chief Scientific Officer
Chief Scientific Officer
504.27K
+781.00%
Mr. Amnon Gat
Mr. Amnon Gat
Chief Operations Officer
Chief Operations Officer
68.47K
--
Mr. Raphi Levy
Mr. Raphi Levy
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Ronen Segal
Mr. Ronen Segal
Chief Technology Officer
Chief Technology Officer
--
--
Prof. Itzhak Kelson
Prof. Itzhak Kelson
Chief Physics Officer
Chief Physics Officer
--
--
Dr. Robert Den, M.D.
Dr. Robert Den, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Ruth Alon
Ms. Ruth Alon
Director
Director
--
--
Dr. S. Morry Blumenfeld, Ph.D.
Dr. S. Morry Blumenfeld, Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Uzi Sofer
Mr. Uzi Sofer
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
11.52M
--
Mr. Michael Avruch
Mr. Michael Avruch
Independent Director
Independent Director
1.55M
+2708.00%
Prof. Yona Keisari
Prof. Yona Keisari
Chief Scientific Officer
Chief Scientific Officer
504.27K
+781.00%
Mr. Amnon Gat
Mr. Amnon Gat
Chief Operations Officer
Chief Operations Officer
68.47K
--
Mr. Raphi Levy
Mr. Raphi Levy
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Ronen Segal
Mr. Ronen Segal
Chief Technology Officer
Chief Technology Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Feb 4
Updated: Wed, Feb 4
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Oramed Pharmaceuticals Inc
16.55%
Sofer (Uzi)
13.51%
Avruch (Michael)
1.82%
Hightower Advisors, LLC
0.81%
Keisari (Yona)
0.59%
Other
66.73%
Shareholders
Shareholders
Proportion
Oramed Pharmaceuticals Inc
16.55%
Sofer (Uzi)
13.51%
Avruch (Michael)
1.82%
Hightower Advisors, LLC
0.81%
Keisari (Yona)
0.59%
Other
66.73%
Shareholder Types
Shareholders
Proportion
Corporation
16.55%
Individual Investor
16.16%
Investment Advisor
2.47%
Investment Advisor/Hedge Fund
0.72%
Hedge Fund
0.21%
Research Firm
0.05%
Bank and Trust
0.02%
Venture Capital
0.01%
Other
63.81%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
47
2.15M
2.50%
--
2025Q3
54
2.18M
2.66%
+245.80K
2025Q2
48
1.93M
2.17%
+414.57K
2025Q1
48
1.52M
2.85%
-495.42K
2024Q4
46
1.33M
2.80%
+27.93K
2024Q3
50
1.30M
4.99%
-29.19K
2024Q2
53
1.33M
5.76%
-530.87K
2024Q1
56
1.86M
5.76%
-2.16M
2023Q4
128
1.91M
37.70%
+832.42K
2023Q3
130
1.04M
38.54%
+25.86K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Oramed Pharmaceuticals Inc
14.11M
16.55%
+14.11M
--
Apr 24, 2025
Sofer (Uzi)
11.52M
13.51%
--
--
Jun 30, 2025
Avruch (Michael)
1.55M
1.82%
+2.71K
+0.17%
Mar 01, 2025
Hightower Advisors, LLC
686.55K
0.81%
--
--
Sep 30, 2025
Keisari (Yona)
504.27K
0.59%
+781.00
+0.16%
Mar 01, 2025
HoyleCohen, LLC
269.09K
0.32%
--
--
Jun 30, 2024
Kovitz Investment Group Partners, LLC
203.23K
0.24%
-1.60K
-0.78%
Sep 30, 2025
Levin Capital Strategies, L.P.
204.71K
0.24%
+12.20K
+6.34%
Sep 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
